HIV-1 Drug Resistance and Associated Risk Factors in Patients with Antiretroviral Therapy Failure in Chongqing, China, 2019-2023

This dataset is derived from a retrospective observational cohort study conducted in Chongqing, China, aiming to characterize drug resistance mutations and identify associated risk factors in HIV/AIDS patients experiencing antiretroviral therapy (ART) failure. The study included patients at Chongqing Public Health Medical Center who met the virological failure criteria (VL > 1000 copies/mL) between January 2019 and December 2023. The dataset encompasses demographic information, clinical indicators, ART regimens, genotypic drug resistance testing results, and HIV-1 subtype distribution.